These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2947143)

  • 1. [Coronary insufficiency. In favor of a direct action on the ischemic cell].
    Letac B
    Presse Med; 1986 Oct; 15(35):1744-5. PubMed ID: 2947143
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cellular disorders induced by ischemia. The effect of trimetazidine].
    Labrid C
    Presse Med; 1986 Oct; 15(35):1754-7. PubMed ID: 3024147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-ischemic effects of trimetazidine: 31P-NMR spectroscopy in the isolated rat heart.
    Lavanchy N; Martin J; Rossi A
    Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):97-110. PubMed ID: 3592863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical benefits of a metabolic approach in the management of coronary patients.
    Marzilli M
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V25-30. PubMed ID: 11206100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The action of trimetazidine (TMZ)].
    Petelenz T; Kozakiewicz K; Chruściel TL
    Wiad Lek; 1987 Sep; 40(18):1263-5. PubMed ID: 3328422
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trimetazidine preservation of the energy potential of the myocardium during ischemia and reperfusion. Phosphorus NMR spectroscopy study of the isolated heart].
    Lavanchy N; Martin J; Rossi A
    Presse Med; 1986 Oct; 15(35):1758-61. PubMed ID: 2947146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of trimetazidine on membrane changes induced by oxygen free radicals in human red cells].
    Maridonneau-Parini I
    Presse Med; 1986 Oct; 15(35):1762-4. PubMed ID: 3024148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medicines interacting with mitochondria: anti-ischemic effects of trimetazidine].
    Spedding M; Tillement JP; Morin D; Le Ridant A
    Therapie; 1999; 54(5):627-35. PubMed ID: 10667101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism].
    Lopaschuk GD
    Presse Med; 1998 Dec; 27(39):2100-4. PubMed ID: 9893703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of trimetazidine on a model of in vitro myocardial ischemia].
    Libersa C; Honoré E; Adamantidis M; Rouet E; Dupuis B; Challice C
    Presse Med; 1986 Oct; 15(35):1765-9. PubMed ID: 2947147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trimetazidine and ischemic heart disease. 3d international symposium].
    Presse Med; 1986 Oct; 15(35):1744-92. PubMed ID: 2947144
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of trimetazidine in the long-term treatment of cardiomyopathies of ischemic origin].
    Brottier L; Barat JL; Combe C; Boussens B; Bonnet J; Bricaud H
    Ann Cardiol Angeiol (Paris); 1989 Mar; 38(3):179-82. PubMed ID: 2735733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effect of trimetazidine and nifedipine in guinea-pig hearts subjected to ischaemia.
    Hugtenburg JG; Jap TJ; Mathy MJ; van Heiningen PN; Bohnenn VA; Heijnis JB; Boddeke HW; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1989; 300():186-208. PubMed ID: 2559668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimetazidine in the myocardial cell mechanisms of cytoprotection.
    Labrid C
    Rom J Intern Med; 1998; 36(3-4):137-44. PubMed ID: 10822510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous assessment of the effects of trimetazidine on the myocardium and coronary vasculature of the dog.
    Yanagisawa T; Satoh K; Taira N
    Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):316-29. PubMed ID: 485693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of trimetazidine on the brain metabolism during acute ischemia complicated by hypoxia].
    Smirnov AV; Zarubina IV; Krivoruchko BI; Mironova OP
    Biull Eksp Biol Med; 1999 Mar; 127(3):299-301. PubMed ID: 10225104
    [No Abstract]   [Full Text] [Related]  

  • 17. [Unsolved problems of cytoprotective therapy in patients with coronary heart disease].
    Statsenko ME; Turkina SV; Ermolenko AA
    Ter Arkh; 2015; 87(12):101-106. PubMed ID: 27022658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic importance of trimetazidine in ischemic pathology of the myocardium].
    Schutz DS
    Presse Med; 1986 Oct; 15(35):1788-90. PubMed ID: 2947152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trimetazidine: conclusions of experimental and clinical studies].
    Messner-Pellenc P
    Presse Med; 1986 Oct; 15(35):1791-3. PubMed ID: 2947153
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of the combination of trimetazidine and a calcium inhibitor in the treatment of chronic coronary insufficiency. Double-blind controlled study versus placebo].
    Brochier M; Demange J; Ducloux G; Monpère C; Warin JF
    Ann Cardiol Angeiol (Paris); 1986 Jan; 35(1):49-56. PubMed ID: 3516053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.